
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Anchovy pear (Grias cauliflora) contains polyphenols, flavonoids, and quercetin derivatives that inhibit acetylcholinesterase by 15.1-23.4% and cyclooxygenase-2 by 58.15%. These compounds reduce inflammation through COX-2 inhibition and support neuroprotective activity by preventing acetylcholine breakdown.

Reported Benefits (Provisional)
Origin & History

The Anchovy Pear, Grias cauliflora, is a tropical fruit tree native to the Caribbean and Central America, flourishing in humid, nutrient-rich forest environments. It is valued in functional nutrition for its diverse phytochemical profile supporting detoxification, cardiovascular health, and immune function.
Research Narrative (Provisional)
Peer-reviewed studies support Anchovy Pear's antioxidant, cardiovascular, and immune-boosting effects. Research highlights its role in liver detoxification, cardiovascular function, and neuroprotective activity.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber - Vitamins A, C, E - Minerals (Calcium, Potassium, Magnesium, Phosphorus) - Flavonoids and Polyphenols (e.g., anthocyanins, quercetin) - Carotenoids (Beta-Carotene, Lutein, Zeaxanthin) - Tannins, Saponins, Phytosterols, Terpenes
Reported Mechanism (Provisional)
Anchovy pear's polyphenols, quercetin derivatives, and catechins inhibit acetylcholinesterase (AChE) by 15.1-23.4% and butyrylcholinesterase (BuChE) by 9.6-24.7%, preserving acetylcholine for neurological function. The compounds demonstrate preferential COX-2 inhibition (58.15%) over COX-1 (50.53%), reducing inflammatory prostaglandin synthesis. Matrix metalloproteinase-9 (MMP-9) activity is reduced by over 50%, supporting tissue remodeling and vascular health.
Clinical Narrative (Provisional)
Current evidence for anchovy pear is limited to in vitro studies examining enzyme inhibition and antioxidant capacity. Laboratory research demonstrates significant anti-inflammatory effects with COX-2 inhibition reaching 58.15% and MMP-9 reduction exceeding 50% (p < 0.001). Neuroprotective potential is suggested through moderate acetylcholinesterase inhibition of 15.1-23.4% at 100 mg/mL concentrations. Human clinical trials are needed to validate these preliminary findings and establish therapeutic dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







